THE first trial of stem cell therapy
for arthritic knees is set to start
shortly in Great Britain.
The one year trial will see
patients treated with a mixture of
their own bone marrow stem cells,
mixed with their own carrtilage
cells, via an injection into their
knee at the site of damage or
wear, with results marked on how
effective the treatment is in
developing new quality cartilage.
It is hoped this study will
eventually provide an alternative to
knee replacement surgery.The above article was sent to subscribers in Pharmacy Daily's issue from 26 Jul 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Jul 10
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.